What is the global market size of Microfluidic Devices Market?

Microfluidic Devices Market size was valued at USD 59.7 billion in 2021 and is poised to grow from USD 70.03 billion in 2022 to USD 250.99 billion by 2030, growing at a CAGR of 17.3% in the forecast period (2023-2030).

Microfluidic Devices Companies

Microfluidic Devices Market Competitive Landscape

Microfluidic Devices Market Top Player’s Company Profiles

Danaher Corporation (US)

Thermo Fisher Scientific Inc. (US)

Agilent Technologies, Inc. (US)

PerkinElmer, Inc. (US)

Bio-Rad Laboratories, Inc. (US)

Roche Diagnostics (Switzerland)

Becton, Dickinson and Company (US)

Siemens Healthineers AG (Germany)

Fluidigm Corporation (US)

Dolomite Microfluidics (UK)

Abbott Laboratories (US)

Cepheid (US)

QIAGEN N.V. (Netherlands)

Bio-Rad Laboratories, Inc. (US)

Microfluidic ChipShop GmbH (Germany)

Illumina, Inc. (US)

Cellix Ltd. (Ireland)

Agilent Technologies, Inc. (US)

RainDance Technologies (US)

Dolomite Bio Ltd. (United Kingdom)

Microfluidic Devices Market

FAQs

Microfluidic Devices Market size was valued at USD 82.14 Billion in 2023 and is poised to grow from USD 96.35 Billion in 2024 to USD 345.35 Billion by 2032, growing at a CAGR of 17.3% during the forecast period (2025-2032).

The competitive landscape is shaped by factors such as product innovation, quality, pricing, regulatory compliance, and customer relationships. Established companies with a strong market presence leverage their experience, brand reputation, and extensive distribution networks to maintain a competitive edge. These players often invest significantly in research and development to introduce new and advanced microfluidic devices that meet the evolving needs of customers. 'Danaher Corporation (US)', 'Thermo Fisher Scientific Inc. (US)', 'Agilent Technologies, Inc. (US)', 'PerkinElmer, Inc. (US)', 'Bio-Rad Laboratories, Inc. (US)', 'Roche Diagnostics (Switzerland)', 'Becton, Dickinson and Company (US)', 'Siemens Healthineers AG (Germany)', 'Fluidigm Corporation (US)', 'Dolomite Microfluidics (UK)', 'Abbott Laboratories (US)', 'Cepheid (US)', 'QIAGEN N.V. (Netherlands)', 'Bio-Rad Laboratories, Inc. (US)', 'Microfluidic ChipShop GmbH (Germany)', 'Illumina, Inc. (US)', 'Cellix Ltd. (Ireland)', 'Agilent Technologies, Inc. (US)', 'RainDance Technologies (US)', 'Dolomite Bio Ltd. (United Kingdom)'

There is an increasing market demand for compact and portable devices across various industries, including healthcare, pharmaceuticals, and biotechnology. Microfluidic devices are well-suited to meet this demand due to their small size, reduced sample volumes, and integration of multiple functions. The ability to perform complex laboratory processes on a small scale, along with the convenience of portability and on-site analysis capabilities, are driving the adoption of microfluidic devices in different applications and contributing to market growth.

Increasing adoption of point-of-care testing (POCT) applications: Point-of-care testing refers to diagnostic testing conducted at or near the patient, providing immediate results that facilitate quick decision-making by healthcare professionals. Microfluidic devices have gained significant traction in POCT applications due to their ability to handle small sample volumes, enable rapid analysis, and offer portability and ease of use. These devices are utilized in various healthcare settings, including hospitals, clinics, and home care settings, allowing for faster diagnosis and treatment decisions. The trend towards POCT is driven by the need for rapid and accurate diagnostic information, particularly in emergency and critical care situations.

North America holds a significant share in the Tablet Coatings market due to several factors. The region has a well-established pharmaceutical and healthcare infrastructure, along with a strong presence of key pharmaceutical manufacturers. The demand for tablet coatings in North America is driven by factors such as increasing research and development activities, high healthcare expenditure, and the presence of advanced pharmaceutical manufacturing technologies. Additionally, the region has a higher adoption rate of innovative coating technologies and a focus on quality control and regulatory compliance, further contributing to its dominance in the market.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Microfluidic Devices Market Competitive Landscape

Microfluidic Devices Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Microfluidic Devices Market Competitive Landscape

Microfluidic Devices Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Microfluidic Devices Market?

Who are the key vendors in the Microfluidic Devices Market?

What is the key driver of Microfluidic Devices Market?

What is the key market trend for Microfluidic Devices Market?

Which region accounted for the largest share in Microfluidic Devices Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300